Composition intended for the treatment of amyotrophic lateral sclerosis
AssigneeGemac
InventorMichel Geffard
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of a composition for controlling the evolution of amyotrophic lateral sclerosis, characterised in that it comprises at least: a conjugate of poly-lysine and at least one anti-oxidant, and a conjugate of poly-lysine and at least one fatty acid. The invention also relates to a particular composition for controlling the evolution of amyotrophic lateral sclerosis.
Claims13
1-5. (canceled)
A composition to manage the development of amyotrophic lateral sclerosis, comprising:
- at least one conjugate between poly-lysine and at least one anti-oxidant, and
- at least one conjugate between poly-lysine and at least one fatty acid.
A method of treating amyotophic lateral sclerosis, comprising administering a composition comprising an effective amount of at least one conjugate between poly-lysine and at least one anti-oxidant, and at least one conjugate between poly-lysine and at least one fatty acid to a subject in need thereof.
Dependencies are inferred from the claim text.